<p>Tuhura Biosciences Inc. has received a notice from Nasdaq indicating that its common stock has traded below the $1.00 minimum bid price requirement for 35 consecutive business days, putting the company out of compliance with Nasdaq Listing Rule 5550(a)(2). The company has been granted a 180-day grace period, until July 28, 2026, to regain compliance. If it does not meet the requirement within this period, Tuhura may be eligible for a second 180-day extension, provided it meets other initial listing standards and notifies Nasdaq of its intention to address the deficiency, potentially including a reverse stock split. Failure to regain compliance could result in delisting from the Nasdaq Capital Market. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tuhura Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-031742), on January 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

SBIO

HURA

<p>Tuhura Biosciences Inc. has been notified by Nasdaq for trading below the $1.00 minimum bid price for 35 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The company has a 180-day grace period until July 28, 2026, to regain compliance, with a potential second extension available. Failure to comply may lead to delisting from the Nasdaq Capital Market.</p>

Nasdaq Warns Tuhura Biosciences Over Minimum Bid Price Compliance